Improving Medical Decision Making for Older Patients With End Stage Renal Disease
Trial ID or NCT#
NCT04347629
Status
RECRUITING
Purpose
The overall objective of this study is to reduce the burden of chronic kidney disease (CKD) and its consequences for an aging U.S. population. To accomplish this, the investigators propose to conduct a multi-center randomized trial of an advance care planning (ACP) video intervention (vs. usual care) among older patients with CKD.
Official Title
Improving Medical Decision Making for Older Patients With End Stage Renal Disease
Eligibility Criteria
Ages Eligible for Study: Older than 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
- - Patients age ≥70 are eligible if they have EITHER Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 in the past 12 months NOT determined to be a result of AKI OR Have a diagnosis of CKD and less than a two-year prognosis from any cause, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?") - Patients age 65-69 are eligible if they have BOTH Advanced CKD defined as ONE eGFR value ≤ 30 ml/min/1.73m2 NOT determined to be a result of AKI AND Have less than a two-year prognosis, defined by the clinician answering "NO" to the Surprise Question ("Would you be surprised if this patients died in the next two years?") - Patients who have not had a nephrology visit in the past 12 months can be recruited from non-Nephrology Clinics per the above eligibility criteria
Exclusion Criteria:
- - listed for kidney transplantation or previous transplant recipient - already on or previously on dialysis (including emergent dialysis) - new patient visit - visually impaired beyond 20/200 corrected - psychological state not appropriate for ACP discussions as determined by the primary nephrologist - cognitive impairment
Investigator(s)
Manjula Kurella Tamura
Contact us to find out if this trial is right for you.
Contact
Mitra Kothari
650-493-5000 Ext. 63251
View on ClinicalTrials.gov
